Yes, anti-HCV serology is definitively part of viral serology.
Anti-HCV (antibody to hepatitis C virus) testing is a serological test that detects antibodies against HCV and is a fundamental component of viral serology panels used to diagnose viral hepatitis infections 1.
What Anti-HCV Serology Encompasses
Anti-HCV testing is a serological assay that detects the immune response to HCV infection through antibody detection 1. The testing framework includes:
Screening Tests
- Enzyme immunoassays (EIA) and chemiluminescence immunoassays (CIA) that detect antibodies to HCV-encoded recombinant antigens 1
- These assays target antibodies against HCV core, nonstructural 3 (NS3), nonstructural 4 (NS4), and nonstructural 5 (NS5) proteins 2
Supplemental Serologic Tests
- RIBA (recombinant immunoblot assay) - a more specific supplemental anti-HCV test used to confirm screening-positive results 1
- This confirmatory testing is critical because screening tests can have false-positive rates averaging 35% (range 15-60%) in low-prevalence populations 1
Clinical Context
The term "viral serology" refers to antibody-based testing for viral infections, and anti-HCV clearly falls within this category as it detects the humoral immune response to HCV 3. This is consistent with how other viral hepatitis markers are classified - hepatitis B surface antigen and antibodies are also considered viral serology 1.
Important Caveat
While anti-HCV is serological, the presence of anti-HCV antibodies does not distinguish between current and past infection 1. A positive anti-HCV result requires additional testing with HCV RNA (nucleic acid testing) to determine if active infection is present 1, 4. However, this limitation doesn't change the fact that anti-HCV testing itself is fundamentally a serological test - it simply means that viral serology alone is insufficient for complete HCV diagnosis.